
Molly Liebergall
Senior Writer, Daily Newsletter at Morning Brew
writing and stuff @morningbrew
Articles
-
1 week ago |
morningbrew.com | Molly Liebergall
Publicly traded companies are stockpiling bitcoin as if it’s toilet paper in the year 2020, except they’re betting big money that the digital asset won’t go down the drain. The latest businesses to go for it are GameStop, which announced its first bitcoin purchase, worth ~$500 million, yesterday, and Truth Social’s parent company, Trump Media ($DJT), which said on Tuesday that it’s raising $2.5 billion to create its own bitcoin treasury.
-
2 weeks ago |
morningbrew.com | Molly Liebergall
We’re losing Abraham Lincoln again. After 233 years, the US Treasury will discontinue penny production over the next month, federal officials announced yesterday, following a directive from President Trump. The Treasury will stop circulating one-cent coins by early next year, and shortages will follow:Businesses will have to round prices to the nearest five cents for cash transactions.
-
2 weeks ago |
morningbrew.com | Molly Liebergall
Big-box US retailers are largely in the same boat as they weather tariff uncertainty and inflation. And then there’s Target, which seems to be taking on water faster than its competitors. Yesterday, the company reported another earnings miss and flipped its full-year outlook from positive to negative territory, citing backlash to its DEI rollbacks on top of a “highly challenging environment.”Target’s Q1 sales declined 3% from last year, and the average checkout total dipped 1.4%.
-
2 weeks ago |
morningbrew.com | Molly Liebergall
It’s not about what AI Darth Vader said, it’s about who allegedly didn’t get a say in the bot’s creation: This week, SAG-AFTRA accused Llama Productions, a subsidiary of Fortnite-creator Epic Games, of violating labor agreements by implementing an AI-voiced character without consulting the actors union. Luke, I am your AI companion.
-
2 weeks ago |
morningbrew.com | Molly Liebergall
Sold to the highest bidder: One gargantuan treasure chest of genetic data. Regeneron, the pharmaceutical company that created the world’s first Ebola treatment, has struck a deal to buy the once-hot DNA-testing company 23andMe out of bankruptcy, the drugmaker announced yesterday. Regeneron beat out six other qualified bidders, according to an SEC filing. The $256 million acquisition values 23andMe at less than one-twentieth of its peak ~$6 billion valuation from 2021.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 493
- Tweets
- 170
- DMs Open
- No

RT @DropSiteNews: NEW at @DropSiteNews: The Unbearable Pain of Leaving Gaza Journalist @AbubakerAbedW never wanted to leave his homeland.…

RT @Issaamro: Me showing the world what it means to live Under an apartheid system.

RT @ZohranKMamdani: I said Spanish was kicking my ass, and I meant it. No AI here habibi, just an effort to connect with all New Yorkers.…